European Pharmaceutical Review

NOVEMBER 24, 2022

The number of unauthorised and unregulated online outlets selling counterfeit pharmaceutical products is continuously growing, with many selling counterfeit medications via the internet typically posing as legitimate vendors. Counterfeit medicines and medical supplies can also cause significant harm to people, the report said.

Pharmaceutical 111

Pharmaceutical Manufacturing Pharmaceutical products Distribution 111

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 26 April, 2016.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

European Pharmaceutical Review

APRIL 21, 2023

4 Together with a legal expert from the Bucerius Law School Hamburg, we looked at the legal and political frameworks that could enable the German pharmaceutical sector to become more sustainable.

Pharma 98

Pharma Food and Drug Administration Medicine Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 19, 2023

TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. I Woodhead Publishing Series in Food Science, Technology and Nutrition, Maillard Reactions in Chemistry, Food and Health. Woodhead Publishing.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111

Pharmaceutical Technology

OCTOBER 28, 2022

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Manufacturing 52

Manufacturing Safety Medicine Pharmaceutical 52

European Pharmaceutical Review

APRIL 8, 2025

Q8(R2) Pharmaceutical Development. International Council for Harmonisation (ICH), 2005. Q10 Pharmaceutical Quality System. Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. Q13 Continuous Manufacturing of Drug Substances and Drug Products.

Manufacturing 52

Manufacturing Food and Drug Administration Management Pharmaceutical 52